InvestorsHub Logo
Followers 12
Posts 1128
Boards Moderated 0
Alias Born 12/22/2017

Re: None

Monday, 12/11/2023 12:09:52 PM

Monday, December 11, 2023 12:09:52 PM

Post# of 27409
Clearly time for a management change/upgrade. The retirement of the Old Chaiman who protected Phil Chan opens the path for new talent. The newest Board member was brought on Board for her experience and expertise. Be sure to vote you proxy agains Phil Chan and for Kim. Ideally she becomes the ne CEO.
Ms. Kim is currently a Vice President at Zimmer Biomet, where she serves as the general manager of the Smart Implants portfolio and is responsible for leading the end-to-end program and product management for Zimmer Biomet’s Smart Implants technology in the orthopedic field. Previously, Ms. Kim served as Vice President, Global Strategic Marketing and Chief of Staff for the General Manager, Depression at LivaNova from 2020 to 2021. Prior to LivaNova, from 2011 to 2020, Ms. Kim served in increasing roles of responsibility at Johnson & Johnson Medical Devices. Ms. Kim received her MBA at the MIT Sloan School of Management, and she received a dual degree from the University of Pennsylvania with a B.S. in Economics from The Wharton School and a B.A. in Political Science from The College of Arts and Sciences.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News